Abstract / Summary
This cross-sectional study investigates the distribution and characteristics of essential retail pharmacies (ERPs) designated by the Consolidated Appropriations Act of 2026 and considers policy amendments to ensure patient access to ERPs is protected.
Topics
Pharmaceutical Quality and CounterfeitingOpen access
Primary Source
JAMA Health Forum